Hyperfractionated Dual Equivalent Fractionated Radiation Therapy

Clinical trial NCT06898905 · RECRUITING

Trial details

NCT number: NCT06898905
Sponsor: Yale University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma

Start date: 2025-10-30
Primary completion: 2027-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.